Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "T cell co-stimulatory receptor" refers to a family of cell-surface receptors rather than a single specific molecular target. This represents a broad category encompassing multiple distinct molecules that provide secondary signals necessary for T cell activation alongside T cell receptor (TCR) signaling. These receptors are a diverse group of cell-surface molecules that transduce signals into T cells to positively modulate TCR signaling. They are essential components of the two-signal model of T cell activation; without co-stimulation, T cell activation may lead to anergy, apoptosis, or immune tolerance. Their expression is highly dynamic and context-dependent, allowing for fine-tuned control of immune responses, and their functions are influenced by the tissue microenvironment and the specific ligands or counter-receptors available on surrounding cells.
T cell co-stimulatory receptors, when engaged by their ligands, provide secondary signals (Signal 2) that work in concert with T cell receptor (TCR) signaling (Signal 1) to enable full T cell activation. Agonistic antibodies or molecules targeting these receptors enhance T cell activity by mimicking natural ligand binding, leading to augmented intracellular signaling pathways (e.g., PI3K/AKT, NF-κB, MAPK/ERK). This promotes T cell activation, proliferation, survival, differentiation into effector cells, and enhanced immune responses. Conversely, blocking co-stimulatory pathways or targeting co-inhibitory receptors (which often compete for ligands with co-stimulatory receptors) can reduce T cell activation, leading to anergy, apoptosis, or immune tolerance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell co-stimulatory receptor.